Bavarian Nordic Awarded Ten-Year Contract Amendment valued up to USD 434 million for the Supply of Smallpox and Monkeypox Vaccine to Canada

This extends the USD 56 million contract awarded in June 2022 to a total value of up to USD 470 million.